
Retail · NSE / BSE
Incorporated in 2008, Lenskart is a technology-driven eyewear company involved in designing, manufacturing, branding, and retailing prescription glasses, sunglasses, contact lenses, and accessories. Operating on a direct-to-consumer (D2C) model, it reaches customers through its online platform and a growing network of offline stores. As per the Redseer Report, Lenskart sold the highest volume of prescription eyeglasses in India during FY 2025 and launched 105 new collections, including brand collaborations. As of March 31, 2025, the company operated 2,723 stores—2,067 in India (1,757 owned and 310 franchised) and 656 overseas—and provided remote eye testing at 168 locations across India, Japan, and Thailand. Its centralized manufacturing units are in Bhiwadi and Gurugram, with regional facilities in Singapore and the UAE, enabling next-day delivery in 40 Indian cities and 3-day delivery in 69 cities for single-vision eyewear. The proposed IPO aims to fund new CoCo stores (₹272.62 crore), lease and rent payments (₹591.44 crore), technology and cloud upgrades (₹213.38 crore), brand marketing (₹320.06 crore), and potential acquisitions and general corporate purposes.
Price Band
₹382 – ₹402
Issue Size
₹7278 Cr
Lot Size
37 shares
GMP
+2.0%
Est. Listing
₹410
at current GMP
Subscribed
28.26x
overall
Open
31 Oct 2025
Close
4 Nov 2025
Allotment
6 Nov 2025
Refund
7 Nov 2025
Demat Credit
8 Nov 2025
Listing
10 Nov 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹402
Band: ₹382 – ₹402
Estimated Listing Price
₹410
Upper price + GMP
Lot Size
37 shares
Min investment ₹14,874
Estimated Profit / Lot
₹296
37 × ₹8
Grey Market Premium trend
+₹8
▲ 0 today
Updated 1 minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹8 | 2.0% | ₹410 |
| 30 Oct 2026 | +₹8 | 2.0% | ₹410 |
| 29 Oct 2026 | +₹7 | 1.8% | ₹409 |
GMP is unofficial market data. Not a guarantee of listing performance.
Lenskart Solutions Limited is bringing an initial public offering (IPO) in the Retail sector with an aggregate issue size of ₹7,278.02 Crores. The shares are offered at a price band of ₹382 to ₹402 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 37 shares (approx. ₹14,874 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-11-08, while un-allotted funds or UPI block mandates will be released on 2025-11-07.
The latest grey market premium for Lenskart Solutions Limited IPO is ₹8, which indicates an expected listing price of ₹410.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.